Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines
- PMID: 82545
- DOI: 10.1002/ijc.2910220605
Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines
Abstract
We have studied two types of somatic cell hybrid with regard to expression of the Epstein-Barr virus (EBV) cycle and its regulation. The first, DIP-1, a hybrid formed between two human lymphoma EBV producers (Daudi and P3HR-1), contained EBV DNA, expressed the virus-determined nuclear antigen (EBNA), andwas a producer of the EBV-associated antigens EA (early antigen) and VCA (viral capsid antigen). The second, DAD, a hybrid series of clones formed between Daudi and a HeLa cell derivative (D98), differed with regard to the expression of EBNA, EA, VCA and the content of EBV DNA. EA was regularly induced in the EBV DNA-containing hybrids following treatment with iododeoxyuridine (IdUrd). This induction was greater in lines spontaneously expressing EA. In two hybrids, DIP-1 and DAD10, VCA and virus DNA synthesis were also induced in the presence of IdUrd, the latter being detected by in situ hybridization with P3HR-1 EBV complementary RNA. Finally, while DIP-1 was superinfectable by the P3HR-1 EBV strain, the DAD series of hybrids were refractory to P3HR-1 superinfection and lacked EBV receptors.
Similar articles
-
Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle.Int J Cancer. 1976 Jun 15;17(6):715-24. doi: 10.1002/ijc.2910170605. Int J Cancer. 1976. PMID: 59708
-
Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.J Natl Cancer Inst. 1982 Feb;68(2):197-202. J Natl Cancer Inst. 1982. PMID: 6278188
-
Hybridization between a human epithelial line, infectable by Epstein-Barr virus, and Burkitt lymphoma lines: membrane properties, superinfectability, inducibility and tumorigenicity.Int J Cancer. 1982 Nov 15;30(5):593-600. doi: 10.1002/ijc.2910300510. Int J Cancer. 1982. PMID: 6295967
-
Abortive expression of the Epstein-Barr virus (EBV) cycle in a variety of EBV DNA-containing cell lines, as reflected by nucleic acid hybridization in situ.Int J Cancer. 1979 Nov 15;24(5):679-87. doi: 10.1002/ijc.2910240524. Int J Cancer. 1979. PMID: 93584
-
Segregation of the EBV-determined nuclear antigen (EBNA) in somatic cell hybrids derived from the fusion of a mouse fibroblast and a human Burkitt lymphoma line.Int J Cancer. 1974 Jul 15;14(1):54-64. doi: 10.1002/ijc.2910140108. Int J Cancer. 1974. PMID: 4376508 Review. No abstract available.
Cited by
-
Epstein-Barr virus (EBV), lymphocytes and transformation.J Cancer Res Clin Oncol. 1983;106(1):1-11. doi: 10.1007/BF00399890. J Cancer Res Clin Oncol. 1983. PMID: 6309856 Free PMC article. Review. No abstract available.
-
The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.J Virol. 1995 Jun;69(6):3816-23. doi: 10.1128/JVI.69.6.3816-3823.1995. J Virol. 1995. PMID: 7745729 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources